Document is current
Any future updates will be listed below
-
Authors
Yang, Chun-Ting
Wilkins, James M.
Kesselheim, Aaron S.
Kim, Dae Hyun
Lin, Kueiyu Joshua
-
Funding
Funding for this research was provided by:
Alzheimer's Association (AARF-25-1485126)
National Institute on Aging (K24AG073527)
National Institute on Aging (R01AG075335)
- License Information
-
More Information
Article History
Received: 16 April 2026
Accepted: 29 June 2026
First Online: 6 July 2026
Declarations
:
: This study was approved by the Mass General Brigham Institutional Review Board (#2023P001111). Informed consent was deemed exempt as this study involved the use of secondary data, which were de-identified and did not involve direct interaction with participants.
: Not applicable.
: KJL has received research grants from Takeda, AbbVie, and UCB for projects unrelated to this study. DHK received personal fees from Pfizer, Alosa Health (ended on 12/31/2022) and VillageMD (ended on 12/13/2022) unrelated to this study. ASK reports serving as an expert witness on behalf of a class of individual plaintiffs in a case against Gilead relating to its tenofovir-containing products, on behalf of a payor in a case against Johnson & Johnson regarding patents and biosimilar Stelara entry, on behalf of the Federal Trade Commission in a case against pharmacy benefits managers related to insulin, and on behalf of a group of state attorneys general and payors in a case against multiple generic manufacturers related to alleged price fixing.
